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Abstract
BACKGROUND: Persistent postsurgical pain is a major source of dissatisfaction
after knee arthroplasty. Postoperative pain trajectories allow a dynamic view
of pain resolution after surgery and might help to identify patients at risk for
persistent pain. QUESTIONS/PURPOSES: In this prospective observational
study, we examined the relationship between postoperative pain trajectories and
persistent pain, specifically neuropathic pain, at 3 months after knee arthroplasty.
METHODS: Over a 1-year period, all patients undergoing elective unilateral
knee arthroplasty for osteoarthritis by one surgeon were invited to participate
in the study, provided they had not had prior knee surgery and their American
Society of Anesthesiologists grade was 3 or lower; 128 patients fulfilled these
criteria. Patients filled in a diary questioning postoperative pain at rest and during
mobilization and maximal pain from Day 1 until Day 8 after surgery. At 3 months,
the patients were questioned concerning the ...
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Abstract
Background Persistent postsurgical pain is a major
source of dissatisfaction after knee arthroplasty. Postoper-
ative pain trajectories allow a dynamic view of pain
resolution after surgery and might help to identify patients
at risk for persistent pain.
Questions/purposes In this prospective observational
study, we examined the relationship between postoperative
pain trajectories and persistent pain, specifically neuro-
pathic pain, at 3 months after knee arthroplasty.
Methods Over a 1-year period, all patients undergoing
elective unilateral knee arthroplasty for osteoarthritis by one
surgeon were invited to participate in the study, provided
they had not had prior knee surgery and their American
Society of Anesthesiologists grade was 3 or lower; 128
patients fulfilled these criteria. Patients filled in a diary
questioning postoperative pain at rest and during mobiliza-
tion and maximal pain from Day 1 until Day 8 after surgery.
At 3 months, the patients were questioned concerning the
presence of persistent pain and its nature and intensity using
the Douleur Neuropathique 4 [Neuropathic Pain 4] and Brief
Pain Inventory questionnaires. At 3 months, 112 of the 128
patients (87%) were successfully contacted.
Results At 3 months, 47 of the 112 (42%) patients were
totally pain free and 65 (58%) reported persistent pain at the
surgical site. Among the latter, 12 patients (11%) presented
with a neuropathic component and more severe persistent
pain. Pain trajectories highlighted higher acute pain scores
for maximal pain (from Day 1 until Day 8) and for pain at
mobilization (from Day 3 until Day 8) in patients with neu-
ropathic persistent pain (p \ 0.05 at all time points compared
with the no persistent pain group).
Conclusions Postoperative pain trajectories constructed
from patient’s pain diary suggest that a subgroup of patients
who will present with higher pain at 3 months after knee
arthroplasty might be identified early in the postoperative
period and might benefit from preventative treatment.
Level of Evidence Level III, diagnostic study. See
Instructions for Authors for a complete description of
levels of evidence.
Introduction
Persistent postsurgical pain is a well-known clinical entity
that has become a major focus of interest in the last decade.
Although the exact nature of this type of pain remains
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unclear, strong associations between sensory abnormalities
and persistent pain seem to point to a neuropathic etiology
in many patients with persistent pain [10, 11]. Persistent
pain has been identified as a particular problem after TKA;
two recent reports, a systematic review of prospective
studies [1] and a large cross-sectional survey [13], mention
an incidence of persistent pain of 10% to 34% and up to
53%, respectively, after TKA.
Persistent pain after TKA can result in patient dissatis-
faction [1, 13], and its prevention now represents a
challenge, as it is an indicator of healthcare quality. To
develop effective preventative strategies, it will be impor-
tant to better understand the mechanisms underlying the
persistence of pain and to determine the risk factors with
the aim to target high-risk patients [12]. Among the risk
factors for developing persistent pain, including after TKA,
the most striking one is the severity of acute postoperative
pain [11, 13, 17]. TKA, a major joint surgery, is a very
painful procedure that carries a prevalence of 60% or more
of severe and poorly relieved postoperative pain [23].
However, some patients presenting with severe acute pain
will never develop persistent pain, and so the question
arises: How should physicians best target those who will be
at risk? The current assessment of postoperative pain is
usually limited to the first 24 to 48 hours and very often
does not include movement-evoked pain; a more dynamic
view of the postoperative pain evolution of patients [12]
seems necessary. The development of pain trajectories
(from Day 1 until Days 5–6) may allow us to characterize
individual postoperative pain and thereby identify abnor-
mal acute pain resolution [5]. According to Chapman et al.
[5], a substantial proportion of patients (37% in their series)
experience unresolved postoperative pain at Day 6 after
surgery.
Our working hypothesis is that patients with more
severe early pain trajectories may be at risk for more severe
pain several months into recovery and that these patients’
pain may be more neuropathic in origin. In this observa-
tional prospective study, we therefore examined the
relationship between postoperative pain trajectories and the
persistence of pain at 3 months after knee arthroplasty. We
also questioned the nature of persistent pain, specifically
focusing on the neuropathic component of the pain, as
others have shown that neuropathic pain is usually more
severe and more difficult to alleviate than nociceptive pain
[21].
Patients and Methods
After institutional ethical committee approval and written
consent, all eligible adult patients scheduled for an elective
unilateral knee arthroplasty for osteoarthritis by a single
surgeon (ET) were invited to participate in a prospective
observational study from January 2012 until December
2012. The exclusion criteria were patient’s refusal to par-
ticipate, language barrier, inability to fill in pain score
questionnaires, history of previous open knee surgery, and
infection. Patients with an American Society of Anesthesi-
ologists grade of greater than 3 (ie, very sick patients) were
not asked to participate. One hundred twenty-eight patients
(106 TKAs, 22 unicompartmental knee arthroplasties
[UKAs]) were included in the study. There were 83 women
and 45 men, with a mean ± SD age of 68 ± 10 years.
After general or spinal anesthesia, patients were prepared
and the tourniquet was inflated at 100 mm Hg above systolic
blood pressure. A medial skin incision of 12 cm was made for
all patients. A minimally invasive far-medial subvastus
approach was used for both UKA and TKA [20]. For UKA, an
extramedullary tibial guide and tibia-first technique were
used. A gap-balancing technique was used for the distal
femoral cut. A cemented fixed bearing implant (Zimmer1
Unicompartmental Knee; Zimmer, Inc, Warsaw, IN, USA)
was used for all patients. For TKA, an intramedullary guide
was used for the distal femoral cut and an extramedullary
guide for the tibial cut. A cemented fixed bearing implant
(Vanguard1; Biomet, Inc, Warsaw, IN, USA) with resurfac-
ing of the patella was used in all cases. Local infiltration
analgesia with a cocktail of ropivacaine 0.2%, epinephrine
1:200,000, and clonidine 150 lg, 220-mL total volume, was
used for both UKA and TKA. According to the progression of
the surgical procedure, different zones of the knee were
injected with the ropivacaine cocktail: first, the suprapatellar
pouch and gutters, followed by the femoral and tibial periost;
then, the posterior capsule after femoral and tibial bone cuts;
and finally, the subfascial layers both medially and laterally.
No drains were used. Mobilization was done by active and
passive ROM exercises twice a day with a trained physio-
therapist. Patients performed straight leg raising immediately
after surgery, and when sufficient recovery was attained,
patients were allowed to walk without aid. When independent
ambulation, stair ascent, and 90 of flexion were attained,
discharge criteria were reached. Patients received deep
vein thrombosis prophylaxis with 10 days of enoxaparin
injections.
All patients were managed with intra- and postoperative
multimodal analgesia. On the day of surgery, 1 hour before
the procedure, patients were premedicated with pregabalin
300 mg, celecoxib 200 mg, and paracetamol 1 g. The
technique of anesthesia, either general anesthesia or spinal
anesthesia (15 mg hyperbaric bupivacaine with 2.5 lg
sufentanil), was left at the discretion of the anesthesiologist
in charge of the patient. All patients received an intraop-
erative dose of dexamethasone 4 mg and a local infiltration
of the operative field by the surgeon as previously
described. In the ward, postoperative pain control was
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provided by oral analgesics, including the systematic
administration of paracetamol and celecoxib. An opioid
analgesic, tramadol or oxycodone, was available according
to the degree of pain. All patients underwent early mobi-
lization and were included in an active rehabilitation
program. The same analgesics were prescribed to the
patients when they left the hospital and continued for
3 weeks postoperatively.
During their hospital stay, the patients were taught how to
fill in a pain diary from Day 1 until Day 8 after surgery. At
the end of every postoperative day, they were instructed to
use a numerical rating scale (NRS; 0 = no pain to
10 = worst pain) to rate their average pain at rest and during
mobilization, as well as the maximal pain felt during the
day. The diary also included analgesics consumption and
medication name and dose. All patients left the hospital with
their diary and were told to send it back after completion by
regular mail. Three months after surgery, 128 patients who
had completed and mailed their postoperative pain diary
were contacted by telephone by a research nurse (MNF). We
were able to contact 112 patients (87%), and the remaining
16 patients were excluded from the data analysis. During the
telephone interview, the patients were questioned concern-
ing the persistence of pain related to the arthroplasty.
Patients who reported pain at rest and/or at mobilization
were invited to answer the French versions of the Brief Pain
Inventory (BPI) and Douleur Neuropathique 4 [Neuropathic
Pain 4] (DN4) questionnaires. The BPI is a short but concise
questionnaire that has been largely used to assess the
intensity and impact of pain, specifically neuropathic pain,
on the quality of life [6, 7]. The DN4 is a simple four-
question questionnaire that attempts to distinguish neuro-
pathic pain from nonneuropathic pain [3]. A cutoff score of
4 has a predictive value of 86%, with a sensitivity of 83%
and a specificity of 90%.
Other patient data included preoperative pain intensity
(NRS, 0–10), presence of comorbidities such as diabetes, and
preoperative medications. Before surgery, all patients were
also asked to fill in a questionnaire assessing their mental
state of pain catastrophization (Pain Catastrophizing Scale;
score from 0 to 52) [19] and their state of anxiety (State-Trait
Anxiety Inventory for Adults; score from 0 to 60) [18].
At 3 months after knee arthroplasty, 47 of the 112
(42%) patients were completely pain free and 65 (58%)
reported persistent pain at the surgery site (maximal pain
intensity 4.3 ± 2.0 on the NRS). For the subsequent ana-
lysis of the data, the patients were separated into three
groups: patients without persistent postsurgical pain
(n = 47), patients with persistent pain not characterized as
neuropathic pain (n = 53), and patients with persistent
pain involving a neuropathic component (n = 12).
We performed statistical analysis using SigmaStat1 3.5
(Systat Software GmbH, Erkrath, Germany). Results are
expressed as mean ± SD or median (interquartile range). The
normal distribution of the data was assessed by the Kol-
mogorov-Smirnov test. Several of the data were not normally
distributed and were analyzed using Kruskal-Wallis ANOVA
on ranks with Dunn’s method for pairwise multiple compar-
isons or Mann-Whitney test for unpaired data. Comparisons of
the observed proportions were performed using chi-square
analysis and the Fisher exact test if appropriate. A p value of
less than 0.05 was considered significant.
Results
Among the 65 patients with persistent pain, 12 (18%)
presented with a neuropathic component of the pain, ie,
they had a positive DN4 questionnaire (C 4 of 10 points).
The incidence of neuropathic pain at 3 months after knee
arthroplasty was 11% (12 of 112 patients).
We were unable to identify any preoperative demo-
graphic or clinical predictors of persistent pain at 3 months
after surgery (Table 1). The group with neuropathic pain
reported more pain than the group with pain without a
neuropathic component (Table 2), but the differences in
clinical pain scores between groups were small and of
questionable clinical importance (ie, 2 points for the
average pain). The negative impact of persistent pain on
the daily quality of life was globally higher in the group
with neuropathic pain than in the the group with pain
without a neuropathic component (Table 2). Mood and
common working tasks seemed particularly affected in
patients with neuropathic pain, but here also the clinical
relevance may be questioned as indicated by the small
differences between the scores reported (Table 2). With the
numbers available, the pain-relieving effects of the anal-
gesics used were similar in the two groups (40% versus
60%, p = 0.085) (Table 2).
Postoperative pain trajectories were constructed for the
three groups of patients, based on the pain diaries. Maximal
postoperative pain was higher in the group with neuropathic
pain than in the group without pain from Day 1 until Day 8
(Fig. 1). Postoperative pain associated with mobilization
was also more severe in the group with neuropathic pain
than in the group without pain from Day 3 until Day 8
(Fig. 2). No differences were found among pain trajectories
for pain at rest (data not shown).
Discussion
The persistence of pain after joint arthroplasty is an
important problem because most patients undergo the sur-
gery to relieve pain; hence, not surprisingly, persistent pain
after a procedure such as knee arthroplasty is the primary
Volume 472, Number 5, May 2014 Utility of Postoperative Pain Trajectories 1411
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predictor of dissatisfaction [1, 13]. Our results suggest that a
subgroup of patients who report pain 3 months after knee
arthroplasty, specifically those with the highest persistent
pain scores and for whom a neuropathic component of the
pain is found, might be identified early after the surgical
Table 1. Demographic and clinical data
Variable No PPSP
group (n = 47)
PPSP
group (n = 53)
Neuropathic PPSP
group (n = 12)
p value
Demographic data
Age (years)* 69 ± 9 67 ± 10 66 ± 11 0.371
Sex ratio (female/male) (number of patients) 31/16 32/21 9/3 0.556
BMI (kg/m2)* 28 ± 5 29 ± 5 30 ± 4 0.411
Preoperative data
NRS pain score (0–10 points; 0 = no pain, 10 = worst pain) 3.5 (0–6) 4 (0–6) 6 (2–6) 0.599
Opioid intake (number of patients) 2 5 2 0.381
Antidepressants intake (number of patients) 7 7 4 0.209
Pain Catastrophizing Scale score (of 52 points) 14 (5–18) 10 (3–22) 14.5 (12–23) 0.377
State-Trait Anxiety Inventory for Adults score (of 60 points)* 13 ± 5 13 ± 7 16 ± 7 0.445
Operative data
GA/SA ratio (number of patients) 38/9 42/11 10/2 0.678
TKA/UKA ratio (number of patients) 40/7 45/8 11/1 0.471
Hospital LOS (days) 5 (4–6) 5 (4–6) 4 (4–6) 0.398
* Values are expressed as mean ± SD;  values are expressed as median, with interquartile range in parentheses; PPSP = persistent postsurgical
pain; NRS = numerical rating scale; GA = general anesthesia; SA = spinal anesthesia; UKA = unicompartmental knee arthroplasty;
LOS = length of stay.
Table 2. Quality of life in patients with persistent pain after knee
arthroplasty: nonneuropathic versus neuropathic pain*
Variable PPSP
group
(n = 53)
Neuropathic
PPSP group
(n = 12)
p value
DN4 score (0–10 points) 1 (0–3) 4.5 (4–5.5) \ 0.001
Pain (number of patients)
At rest 32 (60%) 8 (75%) 0.754
At mobilization 45 (85%) 12 (100%) 0.333
At rest and mobilization 24 (45%) 8 (75%) 0.215
NRS pain score (0–10 points; 0 = no pain, 10 = worst pain)
Maximum 4 (2.5–5) 5.5 (4–6.5) 0.126
Minimum 0 (0–0) 0 (0–2) 0.005
Average 1 (0–2) 3 (1–3.5) 0.027
Pain impact on the quality of life (NRS: 0–10 points; 0 = no impact,
10 = worst impact)
Mood 0 (0–0) 0 (0–5.5) 0.008
Social life 0 (0–0) 0 (0–2) 0.026
Walking capacity 0 (0–3) 3 (0–5.5) 0.081
Common work tasks 0 (0–3) 3 (2–5) 0.004
Sleep quality 0 (0–2) 0 (0–4) 0.680
Analgesics intake
(number of patients)
25 (47%) 8 (67%)
Pain-relieving effect (%) 60 (50–70) 40 (30–50) 0.085
* Neuropathic pain versus nonneuropathic pain was determined
according to the score on DN4 questionnaire;  values are expressed
as median, with interquartile range in parentheses; PPSP = persistent
postsurgical pain; DN4 = Douleur Neuropathique 4 [Neuropathic
Pain 4]; NRS = numerical rating scale.
Fig. 1 A graph shows the pain trajectories for maximal pain reported
by the patients in their diaries from Day 1 to Day 8 after surgery for
the three groups: the group with no persistent postsurgical pain
(No PPSP), the group with pain but without a neuropathic component
(PPSP), and the group pain but with a neuropathic component (NeuP
PPSP). Pain scores are expressed as median values. p values are
shown for comparisons between the group without pain and the group
with neuropathic pain.
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procedure. The use of pain trajectories constructed from
patient’s pain diary from Day 1 until Day 8 after surgery
demonstrated that patients at risk displayed a delayed post-
operative pain resolution with higher pain scores,
particularly during mobilization, than other patients.
There are several limitations related to this observational
study. First, in accordance with the International Association
for the Study of Pain’s current definition of persistent
postsurgical pain [14], ie, pain related to a surgical proce-
dure and lasting more than 2 months, our study included
only followup at 3 months. Nonetheless, some patients
presenting with persistent pain may yet recover as the
duration of healing processes remains unknown and depends
on surgery and extent of tissue trauma. Second, although
reaching statistical significance, the clinical relevance of
some of the results reported in Table 2, including pain
scores and impact of neuropathic pain on the patient’s
quality of life, must be interpreted cautiously, as the effect
sizes of the differences between the scores of the patients
with and without a neuropathic component of their pain are
low. Another limitation concerns the absence of physical
examination of the patients with persistent pain and the use
of a single questionnaire, ie, the DN4, to confirm neuro-
pathic pain. The choice of DN4 was based on its simplicity
and ease of application, particularly during a telephone
interview, but other validated tools also distinguish neuro-
pathic from nonneuropathic pain, eg, the Leeds Assessment
of Neuropathic Symptoms and Signs (LANSS) question-
naire, which has also been used during telephone interviews
after TKA [14]. Finally, the inclusion of both UKAs and
TKAs in the study, as well as the use of either spinal or
general anesthesia during the procedure, may deserve some
discussion, although there were no demographic differences
among the groups of patients (Table 1). It is worth noting
that all the patients benefited from a standardized surgical
procedure (minimally invasive technique, single surgeon)
and a standardized postoperative analgesic regimen (multi-
modal analgesia including local infiltration analgesia). To
date, there are no relevant data showing the preventative
effect of any intraoperative anesthetic technique on the
development of persistent pain after knee arthroplasty.
Further, whether UKA is associated with faster recovery and
a lower incidence of persistent pain remains unknown.
We found that patients with more severe early pain as
highlighted by postoperative pain trajectories in the first
week were more likely to continue to report pain and
limitations 3 months after surgery. Others have suggested
that risk factors for the development of persistent pain after
surgery include preoperative factors (ie, anxiety, cata-
strophization, patient’s expectations), intraoperative factors
(ie, degree of tissue injury including nerve lesion), and
postoperative factors [11]. Several of these risk factors
have differed across studies [13, 16]; likewise, in our study,
we did not identify any demographic predictors of persis-
tent pain. A majority of studies, including several after
knee arthroplasty, point to the severity of acute postoper-
ative pain as a predictor of persistent pain [13, 17].
However, knee arthroplasty is a highly painful procedure,
and as many as 70% of patients experience severe acute
pain during the first days [23] while only 20% will develop
persistent pain [1] and only 6% will present with neuro-
pathic pain [8, 22].
Postoperative pain is a dynamic process. The recent
development of acute pain trajectories may afford a more
precise approach to measurement of postoperative pain
than conventional evaluation and allow identification of
abnormal pain resolution [5]. Using this method, Morze
et al. [16] shaped the evolution of pain from week to week
until 12 weeks after TKA and identified patients with a low
preoperative pain score and those with a small reduction in
their worst pain score by Week 4 as a group at risk for
poor pain outcome. Another study, using similar pain tra-
jectories, found that either higher postoperative pain score
at Day 1 or worsening of pain scores during the first week
predicted patients at risk for persistent pain after living
donors for liver transplantation [2]. Our results support the
utility of these pain trajectories as they may point out very
early patients with a delayed pain resolution.
The nature of persistent pain is as important as its
prevalence. One reason for this is that certain types of pain,
such as neuropathic pain, will require specific treatment.
Another is the possibility that a better understanding of the
Fig. 2 A graph shows the pain trajectories for pain during mobili-
zation reported by the patients in their diaries from Day 1 to Day 8
after surgery for the three groups: the group with no persistent
postsurgical pain (No PPSP), the group with pain but without a
neuropathic component (PPSP), and the group pain but with a
neuropathic component (NeuP PPSP). Pain scores are expressed as
median values. p values are shown for comparisons between the
group without pain and the group with neuropathic pain.
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pathophysiologic mechanisms underlying persistent pain
will contribute to designing preventative strategies.
Chronic pain of neuropathic origin is associated with
higher pain intensity and poorer quality of life than chronic
nonneuropathic pain. Its prevalence among patients with
persistent pain differs in various types of surgery and
seems low; one study found that approximately 6% of
patients will develop it after knee arthroplasty, often
involving the infrapatellar branch of the saphenous nerve
[8]. Our results, 11% at 3 months (DN4 questionnaire), are
in agreement with others, with a frequency of 8.7% at
3 months and approximately 6% at 6 months (LANSS
questionnaire) [4] and later (PainDETECT questionnaire)
[22]. Although persistent neuropathic pain only concerns a
small percentage of patients undergoing arthroplasty, it can
cause severe pain that is often difficult to alleviate. We here
noted that 67% of our patients with neuropathic pain were
taking analgesics 3 months after surgery while their pain
was poorly relieved (40% analgesic effectiveness).
Although data remain scarce, some studies have shown
that neuropathic pain can be detected very early after
surgery [9, 15, 18]. In one of those studies, Martinez et al.
[15] demonstrated the predictive value of a positive DN4
score at 48 hours for the development of neuropathic pain
after iliac crest bone harvest. Identification of patients at
risk soon after surgery would permit more aggressive and
earlier secondary prevention. To date, few clinical studies
have been able to show a preventative effect on the
development of persistent pain after knee arthroplasty,
except for the administration of pregabalin 14 days after
TKA [4]. One could hypothesize that pregabalin, which is
used as first-line treatment in neuropathic pain, has targeted
some high-risk patients.
In conclusion, we found that neuropathic pain after knee
arthroplasty only concerns a small percentage of patients,
but those patients report more pain that badly interferes
with their daily quality of life. Our results suggest that
patients who will experience persistent pain with a neuro-
pathic component may be identifiable early in the
postoperative period using pain trajectories and adequate
questionnaires. These findings need to be confirmed at
longer term to ascertain the validity of these tools. Future
directions of research should focus on such early identifi-
cation of high-risk patients to develop preventative
strategies.
References
1. Beswick A, Wylde V, Gooberman-Hill R, Blom A, Dieppe P.
What proportion of patients report long-term pain after total hip
or knee replacement for osteoarthritis? A systematic review of
prospective studies in unselected patients. BMJ Open. 2012;2:
e000435.
2. Bonnet A, Lavand’homme P, France MN, Reding R, De Kock M.
[Postoperative pain trajectories to identify risk of chronic post-
surgical pain in living donors for liver transplantation] [in
French]. Ann Fr Anesth Reanim. 2012;31:945–949.
3. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle
J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-
Schluep H, Lante´ri-Minet M, Laurent B, Mick G, Serrie A, Valade
D, Vicaut E. Comparison of pain syndromes associated with
nervous or somatic lesions and development of a new neuropathic
pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.
4. Buvanendran A, Kroin J, Della Valle C, Kari M, Moric M, Tu-
man K. Perioperative oral pregabalin reduces chronic pain after
total knee arthroplasty: a prospective, randomized, controlled
trial. Anesth Analg. 2010;110:199–207.
5. Chapman C, Donaldson G, Davis J, Bradshaw D. Improving
individual measurement of postoperative pain: the pain trajectory.
J Pain. 2011;12:257–262.
6. Cleeland C, Ryan K. Pain assessment: global use of the Brief
Pain Inventory. Ann Acad Med Singapore. 1994;23:129–138.
7. Erdemoglu AK, Koc R. Brief Pain Inventory score identifying
and discriminating neuropathic and nociceptive pain. Acta Neurol
Scand. 2013 April 18 [Epub ahead of print].
8. Haroutiunian S, Nikolajsen L, Finnerup N, Jensen T. The neu-
ropathic component in persistent postsurgical pain: a systematic
literature review. Pain. 2013;154:95–102.
9. Hayes C, Browne S, Lantry G, Burstal R. Neuropathic pain in the
acute pain service: a prospective study. Acute Pain. 2002;4:45–48.
10. Johansen A, Romundstad L, Nielsen C, Schirmer H, Stubhaug A.
Persistent postsurgical pain in a general population: prevalence and
predictors in the Tromso study. Pain. 2012;153:1390–1396.
11. Kehlet H, Jensen T, Woolf C. Persistent postsurgical pain: risk
factors and prevention. Lancet. 2006;367:1618–1625.
12. Lavand’homme P. The progression from acute to chronic pain.
Curr Opin Anaesthesiol. 2011;24:545–550.
13. Liu S, Buvanendran A, Rathmell J, Sawhney M, Bae J, Moric M,
Perros S, Pope A, Poultsides L, Della Valle C, Shin N, Mc-
Cartney C, Ma Y, Shah M, Wood M, Manion S, Sculco TP. A
cross-sectional survey on prevalence and risk factors for persis-
tent postsurgical pain 1 year after total hip and knee replacement.
Reg Anesth Pain Med. 2012;37:415–422.
14. Macrae WA, Davies HT. Chronic postsurgical pain. In: Crombie
IK, Linton S, Croft P, Von Korff M, LeResche L, eds. Epide-
miology of Pain. Seattle, WA: IASP Press; 1999:125–142.
15. Martinez V, Ben Ammar S, Judet T, Bouhassira D, Chauvin M,
Fletcher D. Risk factors predictive of chronic postsurgical neu-
ropathic pain: the value of the iliac crest bone harvest model.
Pain. 2012;153:1478–1483.
16. Morze C, Johnson N, Williams G, Moroney M, Lamberton T,
McAuliffe M. Knee pain during the first three months after uni-
lateral total knee arthroplasty: a multi-centre prospective cohort
study. J Arthroplasty. 2013;28:1565–1570.
17. Puolakka P, Rorarius M, Roviola M, Puolakka T, Nordhausen K,
Lindgren L. Persistent pain following knee arthroplasty. Eur J
Anaesthesiol. 2010;27:455–460.
18. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA.
Manual for the State-Trait Anxiety Inventory. Palo Alto, CA:
Consulting Psychologists Press; 1983.
19. Sullivan M, Lynch M, Clark A. Dimensions of catastrophic
thinking associated with pain experience and disability in patients
with neuropathic pain conditions. Pain. 2005;113:310–315.
20. Thienpont E. Faster quadriceps recovery with the far medial sub-
vastus approach in minimally invasive total knee arthroplasty.
Knee Surg Sports Traumatol Arthrosc. 2013;21:2370–2374.
21. Torrance N, Smith B, Bennett M, Lee A. The epidemiology of
chronic pain of predominantly neuropathic origin: results from a
general population survey. J Pain. 2006;7:281–289.
1414 Lavand’homme et al. Clinical Orthopaedics and Related Research1
123
22. Wylde V, Hewlett S, Learmonth I, Dieppe P. Persistent pain after
joint replacement: prevalence, sensory qualities, and postopera-
tive determinants. Pain. 2011;152:566–572.
23. Wylde V, Rooker J, Halliday L, Blom A. Acute postoperative pain at
rest after hip and knee arthroplasty: severity, sensory qualities and
impact on sleep. Orthop Traumatol Surg Res. 2011;97:139–144.
Volume 472, Number 5, May 2014 Utility of Postoperative Pain Trajectories 1415
123
